Intellia Therapeutics, Inc. (NTLA)
12.50
+0.63
(+5.31%)
USD |
NASDAQ |
Jan 16, 16:00
12.50
0.00 (0.00%)
After-Hours: 20:00
Intellia Therapeutics EPS Diluted (Quarterly): -0.9196 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Beam Therapeutics, Inc. | -1.099 |
| ANI Pharmaceuticals, Inc. | 1.133 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Pacific Biosciences of California, Inc. | -0.1263 |
| Twist Bioscience Corp. | -0.4491 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -101.32M |
| Revenue (Quarterly) | 13.78M |
| Total Expenses (Quarterly) | 115.11M |
| Enterprise Value | 1.035B |
| Gross Profit Margin (Quarterly) | 64.19% |
| Profit Margin (Quarterly) | -735.2% |
| Earnings Yield | -34.13% |
| Normalized Earnings Yield | -33.74 |